Saguaro Biosciences
Medical AI · Drug Discovery
Overview
Discover our non-toxic dyes for live-cell imaging. Saguaro dyes are data-rich and do not require any wash step, pushing beyond the limits of cell painting, real-time viability, and complex in vitro models like 3D cultures and iPSCs.
Funding and backers
Total raised
$3M
1 round on record
Latest round
$3M
Seed · Jun 2024 · 2 yr ago
Team
11-50
employees, estimated range
Backers
1
Anges Québec
The money's age
Long since its last round
29 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 15, 2025
Partnership Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents · YahooFinance
Jun 4, 2024
Raised a round Seed $3M
Jun 2021
Website went live first capture in the Wayback Machine
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Seed | Jun 2024 | $3M | — | businesswire.com |
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
backs Talus Bio
backs CytoTronics
Similar startupsby what they do, their industry and backers
PhenoVista Biosciences is a CRO specializing in in vitro cell-based assays and high-content imaging services in the preclinical phase of…
At Ncardia, we are pioneers in iPSC technology providing high-quality cells, relevant screening assays and robust iPSC differentiation…
Human iPSC-derived hepatocytes, organoids and AI-powered Cell Painting for predictive drug discovery. Trusted by AstraZeneca, Sanofi, Deep…
Talus Bio makes the regulome—the control layer of gene expression—visible, measuring and modulating gene regulators in live cells to access…
FROM CELLS TO ORGANELLES• ORGANELLES•. First-in-Class Isolated Organelles for Drug Discovery.
Visualize live cell function at scale with Pixel™: power cell biology discovery with insights on viability, morphology, ephys, & more.
Financials
Total raised
$3M
Latest round
Seed
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Seed | 2024 | $3M | Details |
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Anges QuébecVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents Financial Post
Read more
Report
Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents
QUEBEC CITY, October 15, 2025--Saguaro Biosciences, a pioneer in non-toxic live cell reagents for enhanced drug insights, announces a new distribution agreement with Bio-Techne Corporation (NASDAQ:TECH), a global provider of life science tools, reagents a
Read more
Report
